Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study
Background/Aims Olmesartan, a widely used angiotensin II receptor blocker (ARB), has been linked to sprue-like enteropathy. No cases of olmesartan-associated enteropathy have been reported in Northeast Asia. We investigated the associations between olmesartan and other ARBs and the incidence of ente...
Main Authors: | Seng Chan You, Hojun Park, Dukyong Yoon, Sooyoung Park, Boyoung Joung, Rae Woong Park |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Association of Internal Medicine
2019-01-01
|
Series: | The Korean Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.kjim.org/upload/pdf/kjim-2017-002.pdf |
Similar Items
-
Enteropathy Associated with Olmesartan
by: Bruno Moreira da Silva, et al.
Published: (2016-03-01) -
Angioprotection role in arterial hypertension treatment: focus on olmesartan
by: D. V. Nebieridze, et al.
Published: (2012-10-01) -
LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01) -
Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy
by: Marta Eusébio, et al.
Published: (2016-03-01) -
Olmesartan-Associated Enteropathy: An Unexpected Cause of Chronic Diarrhoea
by: Mónica Martins Teixeira, et al.
Published: (2019-04-01)